Tenaya Therapeutics Presents Interim Data from MyClimb Natural History Study of MYBPC3-associated HCM Pediatric Patients at European Society of Cardiology Congress 2025 Biotech Investing
Exelixis Announces Appointment of Dana T. Aftab, Ph.D. as Executive Vice President, Research and Development Biotech Investing
Pasithea Therapeutics Updates Time of Presentation at the H.C. Wainwright 27th Annual Global Investment Conference Biotech Investing
ABVC BioPharma Receives $450,000 in Licensing Payments From OncoX BioPharma in Q3 2025 Pharmaceutical Investing
